Pharma news

Reset all filters
Geography
Company
Refine search
Dassault Systèmes makes $5.8bn health data deal
Pharma
Software company Dassault Systèmes has targeted the life sciences sector with the $5.8 billion acquisition of Medidata Solutions, a US-firm firm focused on clinical trials.   13 June 2019
India to make barcoding mandatory on all drugs
Pharma
India is to make barcoding mandatory on all medicines sold within the country after a recent report by the Office of the US Trade Representative (USTR) identified the country as the largest producer of counterfeit pharmaceuticals in the world.   11 June 2019
Merck strengthens immunotherapy expertise with $773m buy
Americas
US-based Merck & Co has announced plans to buy Tilos Therapeutics, its latest acquisition in the immunotherapy space.   11 June 2019
Americas
Eli Lilly has asked the US Supreme Court to reconsider a lower court’s ruling which ordered the drugmaker to pay Germany-based Erfindergemeinschaft UroPep $20 million for patent infringement.   10 June 2019
Pharma
A group of more than 100 medical, scientific, patient advocacy and women’s health organisations have opposed a recent proposal to amend section 101 of the US Patent Act.   6 June 2019
Americas
San Francisco-based biotech company Atomwise could be set to receive up to $1 million per target in milestone payments following a partnership agreement with Eli Lilly.   6 June 2019
Pharma
A German court has rejected a bid from French pharmaceutical company Sanofi to have a patent infringement case dismissed.   5 June 2019
Pharma
A Japanese court has dismissed a patent infringement lawsuit brought by Roche subsidiary Genentech against Sandoz, a division of Novartis.   4 June 2019
Pharma
The US Food and Drug Administration has sent a warning letter to a stem cell company for marketing a number of unapproved treatments for a variety of life-threatening conditions.   4 June 2019
Americas
American pharmaceutical company Eli Lilly has secured an exclusive licence for a non-opioid, non-addictive chronic pain treatment from Boston-based biotech company Centrexion Therapeutics.   3 June 2019